Cannabinoid CB1 and Dopamine D1 Receptors Partnership in the Modulation of Emotional Neural Processing

Affiliations

Irit Akirav et al. Front Behav Neurosci. 2011.

. 2011 Oct 13:5:67.

doi: 10.3389/fnbeh.2011.00067. eCollection 2011.

No abstract available

Comment on

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors.
Terzian AL, Drago F, Wotjak CT, Micale V. Terzian AL, et al. Front Behav Neurosci. 2011 Aug 17;5:49. doi: 10.3389/fnbeh.2011.00049. eCollection 2011. Front Behav Neurosci. 2011. PMID: 21887137 Free PMC article.

1. Charney D. S., Davis M., Deutch A. Y., Krystal J. H., Southwick S. M. (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Arch. Gen. Psychiatry 50, 295–305 - PubMed
1. Chiu C. Q., Puente N., Grandes P., Castillo P. E. (2010). Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 30, 7236–724810.1523/JNEUROSCI.0736-10.2010 - DOI - PMC - PubMed
1. de la Mora M. P., Gallegos-Cari A., Arizmendi-García Y., Marcellino D., Fuxe K. (2010). Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog. Neurobiol. 90, 198–21610.1016/j.pneurobio.2009.10.010 - DOI - PubMed
1. El-Ghundi M., O'Dowd B. F., George S. R. (2001). Prolonged fear responses in mice lacking dopamine D1 receptor. Brain Res. 892, 86–9310.1016/S0006-8993(00)03234-0 - DOI - PubMed
1. Ferrer B., Asbrock N., Kathuria S., Piomelli D., Giuffrida A. (2003). Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur. J. Neurosci. 18, 1607–161410.1046/j.1460-9568.2003.02896.x - DOI - PubMed